基本信息
浏览量:6
职业迁徙
个人简介
Prof. Bruix has been the principal investigator of studies and clinical trials that have changed practice in the field of hepatocellular carcinoma (HCC), including development of diagnostic criteria and prognostic models and establishment of chemoembolization and sorafenib as conventional therapy. He developed the BCLC staging and treatment strategy that has been endorsed by several international scientific associations to guide management of patients with HCC. He has also authored more than 200 original investigations and led the development of Evidence-Based Practice Guidelines for Hepatocellular Carcinoma at EASL, AASLD, and the World Gastroenterology Organisation (WGO)
研究兴趣
论文共 741 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Miguel Angel Merlos Rodrigo,Hana Michalkova,Ana Maria Jimenez Jimenez, Frantisek Petrlak,Tomas Do,Ladislav Sivak,Yazan Haddad, Petra Kubickova, Vivian de los Rios, J. Ignacio Casal,Marina Serrano-Macia,Teresa C. Delgado,
crossref(2023)
crossref(2023)
JOURNAL OF HEPATOLOGY (2023): S579-S580
Hepatology (Baltimore, Md.)no. 1 (2023): 12-14
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn